Bariatric surgery for weight loss shows greater long-term benefits than GLP-1 medicinesBariatric surgery for weight loss shows greater long-term benefits than GLP-1 medicines
A large Cleveland Clinic study has found that people with obesity and type 2 diabetes who undergo weight-loss surgery live longer and face fewer serious health problems compared with those treated with GLP-1 receptor agonist medicines alone. A large Cleveland Clinic study has found that people with obesity and type 2 diabetes who undergo weight-loss Read More
About one in five people taking Ozempic, Wegovy or Mounjaro say food tastes saltier or sweeter than beforeAbout one in five people taking Ozempic, Wegovy or Mounjaro say food tastes saltier or sweeter than before
New research being presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria (15–19 September) shows that some individuals who are taking Ozempic, Wegovy or Mounjaro find that foods taste sweeter or saltier than before. New research being presented at the Annual Meeting of the European Association Read More
Higher doses of semaglutide can safely enhance weight loss for adults living with obesity, clinical trials confirmHigher doses of semaglutide can safely enhance weight loss for adults living with obesity, clinical trials confirm
A higher weekly dose of semaglutide (7.2 mg) can significantly improve weight loss and related health outcomes in adults living with obesity, including those with type 2 diabetes (T2D), according to the results of two large-scale, international phase 3 clinical trials. A higher weekly dose of semaglutide (7.2 mg) can significantly improve weight loss and Read More
Weight-loss drug semaglutide shown to reduce cocaine use in ratsWeight-loss drug semaglutide shown to reduce cocaine use in rats
Scientists have found that the diabetes/weight loss drug semaglutide, sold commercially under brand names like Ozempic and Wegovy, significantly reduces cocaine-seeking behavior in rats. This work needs to be confirmed in humans, but it suggests that semaglutide is a candidate to be developed as a treatment for cocaine dependency; at the moment there is no Read More
6 Lifestyle Changes to Prepare For if Your Doctor Suggested a GLP-1 to Treat Obesity6 Lifestyle Changes to Prepare For if Your Doctor Suggested a GLP-1 to Treat Obesity
GLP-1s can be a game changer, but lifestyle habits are still important. GLP-1s can be a game changer, but lifestyle habits are still important.
The next Ozempic: A 4-in-1 breakthrough for lasting weight lossThe next Ozempic: A 4-in-1 breakthrough for lasting weight loss
Scientists are racing to improve weight loss treatments beyond drugs like Ozempic and Wegovy, which are effective but plagued by nausea, bone loss, and weight regain. Tufts University chemists have created a new multi-target compound that goes beyond the usual GLP-1, GIP, and glucagon approaches by adding a fourth hormone, PYY. This “quadruple-action” design aims Read More
The next Ozempic: A 4-in-1 breakthrough for lasting weight lossThe next Ozempic: A 4-in-1 breakthrough for lasting weight loss
Scientists are racing to improve weight loss treatments beyond drugs like Ozempic and Wegovy, which are effective but plagued by nausea, bone loss, and weight regain. Tufts University chemists have created a new multi-target compound that goes beyond the usual GLP-1, GIP, and glucagon approaches by adding a fourth hormone, PYY. This “quadruple-action” design aims Read More
GLP-1 receptor agonists, cancer risk and questionable significanceGLP-1 receptor agonists, cancer risk and questionable significance
Research led by the Indiana University School of Medicine and the University of Florida reports an association between taking GLP-1 receptor agonists and lower overall cancer risk in adults with obesity or overweight, with a reduced risk for ovarian cancer and a possible increased risk of kidney cancer. Research led by the Indiana University School Read More
Losing weight but gaining weakness? What Ozempic might be doing to your musclesLosing weight but gaining weakness? What Ozempic might be doing to your muscles
Ozempic’s weight loss benefits might come at the cost of muscle strength, even if muscle size remains relatively stable. This raises significant concerns for older adults, who are already at risk for muscle loss and reduced mobility. Researchers stress the urgent need for human clinical trials to understand these effects fully. Ozempic’s weight loss benefits Read More
Losing weight but gaining weakness? What Ozempic might be doing to your musclesLosing weight but gaining weakness? What Ozempic might be doing to your muscles
Ozempic’s weight loss benefits might come at the cost of muscle strength, even if muscle size remains relatively stable. This raises significant concerns for older adults, who are already at risk for muscle loss and reduced mobility. Researchers stress the urgent need for human clinical trials to understand these effects fully. Ozempic’s weight loss benefits Read More